Tara Greene joined Inozyme Pharma in September 2019 and serves as the Interim Vice President of Quality and Compliance. In this role, Ms. Greene is responsible for developing and leading the quality management systems at Inozyme and establishing a robust company culture. Currently, she is the Owner & Principal Consultant of BioEthicA, LLC.

Ms. Greene has more 20 years of biopharmaceutical experience. Her experience comes from both industry, as Site Director of Quality at Patheon Biologics, and in the public space, through her previous role at the U.S. FDA as a Pharmaceutical Inspectorate and Drug Specialist. Her expertise spans from radiopharmaceuticals to biotechnology, to cell and gene therapy drug products. She has an extensive background in US FDA quality regulations and has a thorough knowledge of EMA regulations (inclusive of ICH), interpretation, and application.

Ms. Greene earned her B.S. from Kansas State University in 1999 and her M.S. in Biomedical Quality Systems from San Diego State University in 2008.